Piotr Popik Selected Research

1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)urea

1/2021	Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1/2 and Arc genes in rats.
1/2020	Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Popik Research Topics

Disease

22	Schizophrenia (Dementia Praecox) 01/2021 - 01/2010
20	Cognitive Dysfunction 01/2021 - 12/2010
6	Alzheimer Disease (Alzheimer's Disease) 06/2022 - 01/2016
5	Memory Disorders (Memory Loss) 12/2020 - 01/2016
4	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2021 - 10/2017
4	Opioid-Related Disorders (Opiate Addiction) 01/2013 - 03/2003
3	Treatment-Resistant Depressive Disorder 10/2020 - 11/2009
3	Premenstrual Dysphoric Disorder 01/2009 - 01/2007
2	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020 - 01/2019
2	Hypersensitivity (Allergy) 10/2020 - 11/2006
2	Mood Disorders (Mood Disorder) 06/2015 - 01/2007
2	Pain (Aches) 11/2010 - 06/2007
2	Morphine Dependence 12/2005 - 03/2003
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	AIDS-Related Complex (ARC) 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Mental Disorders (Mental Disorder) 01/2018
1	Dementia (Dementias) 01/2016
1	Bipolar Disorder (Manic Depressive Psychosis) 06/2015

Drug/Important Bio-Agent (IBA)

15	Ketamine FDA LinkGeneric 01/2021 - 01/2010
14	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 11/2009
6	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 01/2006
5	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 01/2021 - 08/2015
5	Antidepressive Agents (Antidepressants)IBA 10/2017 - 01/2006
4	Dopamine (Intropin)FDA LinkGeneric 01/2021 - 01/2006
4	Scopolamine (Hyoscine)FDA Link 12/2020 - 01/2018
4	Glutamic Acid (Glutamate)FDA Link 10/2020 - 12/2005
3	serotonin 6 receptorIBA 01/2021 - 05/2013
3	Antipsychotic Agents (Antipsychotics)IBA 03/2020 - 01/2016
3	Memantine (Namenda)FDA Link 01/2020 - 02/2011
3	Phencyclidine (Angel Dust)IBA 01/2018 - 06/2011
2	1- (5- chloro- 2,4- dimethoxyphenyl)- 3- (5- methylisoxazol- 3- yl)ureaIBA 01/2021 - 01/2020
2	Hormones (Hormone)IBA 01/2021 - 01/2007
2	SteroidsIBA 01/2021 - 01/2011
2	LigandsIBA 01/2021 - 12/2020
2	CorticosteroneIBA 01/2021 - 01/2011
2	Pramipexole (Mirapex)FDA LinkGeneric 01/2021 - 01/2019
2	Amphetamine (Amfetamine)FDA LinkGeneric 10/2020 - 02/2015
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2020 - 10/2016
2	Donepezil (Aricept)FDA LinkGeneric 01/2020 - 01/2018
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2020 - 01/2006
2	quinolineIBA 01/2019 - 01/2016
2	Pharmaceutical PreparationsIBA 10/2017 - 01/2011
2	3- benzenesulfonyl- 8- piperazin- 1- ylquinolineIBA 06/2016 - 01/2016
2	serotonin 7 receptorIBA 07/2013 - 01/2013
2	N-Methylaspartate (NMDA)IBA 01/2010 - 11/2009
2	Estrogens (Estrogen)FDA Link 01/2009 - 07/2007
2	Progesterone FDA LinkGeneric 01/2009 - 07/2007
2	Morphine (MS Contin)FDA LinkGeneric 12/2005 - 03/2003
1	Monoamine Oxidase (MAO)IBA 06/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Tiagabine (Gabitril)FDA Link 01/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 01/2021
1	Testosterone (Sustanon)FDA Link 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Ondansetron (Zofran)FDA LinkGeneric 01/2021
1	gamma-Aminobutyric Acid (GABA)IBA 01/2021
1	5-HT3 Serotonin Receptors (5 HT3 Receptor)IBA 01/2021
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 10/2020
1	EsketamineIBA 10/2020
1	CannabidiolIBA 03/2020
1	CannabinoidsIBA 03/2020
1	Galantamine (Galanthamine)FDA LinkGeneric 01/2020
1	Buspirone (Buspar)FDA LinkGeneric 01/2020
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2020
1	Methylazoxymethanol AcetateIBA 01/2020
1	NeurotoxinsIBA 01/2020
1	naphthaleneIBA 10/2019
1	AminesIBA 10/2019
1	dihydrexidineIBA 01/2019
1	Dopamine D3 ReceptorsIBA 01/2019
1	rotigotine FDA Link 01/2019
1	Bromocriptine (Parlodel)FDA LinkGeneric 01/2019
1	Modafinil (Provigil)FDA Link 01/2019
1	pyrrolidineIBA 01/2019
1	Cholinergic ReceptorsIBA 12/2018
1	PNU-282987IBA 12/2018
1	Varenicline (Chantix)FDA Link 12/2018
1	metanicotineIBA 12/2018
1	Therapeutic UsesIBA 02/2018
1	Dopamine D2 Receptors (Dopamine D2 Receptor)IBA 02/2018
1	Nootropic Agents (Nootropics)IBA 01/2018
1	compound 17IBA 01/2018
1	Metabotropic Glutamate 5 ReceptorIBA 01/2018
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 10/2017
1	Clonidine (ST 155)FDA LinkGeneric 10/2017
1	positive allosteric modulator PAM-2IBA 01/2017
1	3-(2,4-dimethoxybenzylidene)anabaseineIBA 01/2017
1	alpha7 Nicotinic Acetylcholine ReceptorIBA 01/2017
1	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2017
1	serotonin 5 receptorIBA 01/2016
1	SCH 23390IBA 01/2016
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 01/2016
1	Excitatory Amino Acid AntagonistsIBA 12/2015
1	LithiumIBA 06/2015
1	Valproic Acid (Depakote)FDA LinkGeneric 06/2015

Therapy/Procedure

5	Therapeutics 01/2021 - 05/2013
3	Drug Therapy (Chemotherapy) 01/2019 - 02/2011